|
Reference #:
2006-202
Inventors/Contributors
John L. Black, III, M.D., David A Mrazek, M.D., Dennis J. O'Kane, Ph.D.
Description
The CYP2D6 gene makes a protein that metabolizes drugs. This gene is highly variable. It can have different amino acids in various positions, it can be deleted, it can be partly deleted, it can be duplicated and it can have other changes that alter the way the gene works. Tests are available for all of these changes. However, some individuals have genes that cannot be tested and give unusual readings on standard testing platforms. We have discovered that some of these individuals have a gene that is created by a heretofore unrecognized crossover between chromosomes. This crossover creates two new arrangements. One arrangement is a blend of CYP2D6 and CYP2D7 (in that order), has a CYP2D7 upstream of it and is followed by a sequence usually seen only in CYP2D6*5 (we have named this "Neogene A with 2D7 present"). The other gene is a blend of CYP2D7 and CYP2D6 (in that order) and it has no upstream CYP2D7 sequence (we have named this Neogene B with CYP2D7 absent). We describe a test for these arrangements.
Patent Status
Pending |
|
Contact
Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 284-1222
Fax: (507) 284-5410
|
|
|